Skip to menu Skip to content Skip to footer

Detection and treatment of triple negative breast cancer: development of novel nanomedicine devices allowing simultaneous molecular imaging, gene therapy and aptamer therapy (2014-2016)

Experts

Professor Kristofer Thurecht

Senior Group Leader and Deputy Director, Research (AIBN/CAI)
Australian Institute for Bioengineering and Nanotechnology
Kristofer Thurecht